Description
+ Include: 30 videos + 1 pdf, size: 36 GB
+ Target Audience: hematologist, oncologist
+ Sample video: contact me for sample video
+ Information:
The EBMT and the European Hematology Association (EHA) are excited to announce the 5th edition of the jointly organised European CAR T-cell Meeting.
Date: 9-11 February 2023
Location: Rotterdam, The Netherlands
Format: Hybrid & Virtual
Chairs: Michael Hudecek & Anna Sureda
The meeting will cover a broad range of topics including deep science and translational, clinical and commercial development in the field of CAR T. The programme will bring you all the latest in CAR T and will even bring in the first ever reported clinical data.
Join the meeting to be able to hear the latest developments and to have the chance to discuss this important topic with both experts and your peers.
Target Audience
The target audience is haematologists, oncologists, physicians, nurses, data managers, supply chain managers and patient organization representatives.
Programme
The programme will cover various CAR T-cell related topics and will include keynote lectures, interactive debate sessions and more. Please check the preliminary programme here.
Scientific Programme Committee
The meeting is led by Anna Sureda and Michael Hudecek, in close collaboration with the Scientific Programme Committee (SPC). Together they have created the programme. The members are:
- Raffaella Greco (Italy)
- Claire Roddie (United Kingdom)
- Ibrahim Yakhoub-Agha (France)
- Maria Themeli (The Netherlands)
- Annalisa Ruggeri (Italy)
- Ulrich Jäger (Austria)
- Michelle Kenyon (United Kingdom)
- Erik Aerts (Switzerland)
- Natacha Bolaños (Spain)
- Solène Clavreul (France)
- Valentin Ortiz-Maldonado (Spain)
- Eleni Gavriilaki (Greece)
+ Topics:
pdf-program.pdf
Advanced concepts for CAR-T manufacturing.mp4
Best Abstract Session & Awards.mp4
Best Abstract Session BA2.mp4
Best Abstract Session BA3.mp4
Bringing CAR T into second line in DLBCL Satellite symposium sponsored by Kite.mp4
CAR-T Cell Therapy expends the horizon for patients with Multiple Myeloma Satellite Symposium by Janssen.mp4
CAR-T Innovation Pipeline.mp4
Clinical Indications I – Lymphomas.mp4
Clinical Indications II – Acute & Chronic Leukaemias.mp4
Clinical Indications III – Multiple Myeloma.mp4
Clinical Indications IV – Solid Tumors & Keynote lecture.mp4
Clinical Management of CAR-T Patients.mp4
Closing remarks.mp4
Failure of CAR-T – What is next.mp4
International Session – Access to CAR-T on a Global Scale.mp4
Keynote Lecture Antigen sensitivity, persistence and gated control of CAR T cells.mp4
Keynote Lecture Bringing CAR T to the next generation for efficacy and safety.mp4
Keynote Lecture Journey to CAR-T Cell Therapy & Beyond, Emily Whitehead’s Story.mp4
Keynote Lecture Mechanisms driving CAR T cells.mp4
New Academic Initiatives & CAR-T Therapy Networks.mp4
Opening and Session 1.mp4
Opening Ceremony.mp4
Patient perspective on CAR-T Round table.mp4
Satellite Symposium Optimizing CAR T cell therapy experience in the real world an outsidethe-box discussion by Bristol Myers Squibb.mp4
Session 2.mp4
Session 3.mp4
Session 4.mp4
Session 5.mp4
Session 6 and closing.mp4
Toxicity Management.mp4
Reviews
There are no reviews yet.